Áö¹æ ¾Æ¹Ìµå ½ÃÀå : Á¦Ç° À¯Çüº°, Çüź°, Áö¿ªº°
Fatty Amides Market, By Product Type (Erucamide, Oleamide, Stearamide, Behenamide), By Form (Powder, Beads, Micro-beads, Pastilles), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
»óǰÄÚµå
:
1449650
¸®¼Ä¡»ç
:
Coherent Market Insights
¹ßÇàÀÏ
:
2024³â 02¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹®
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
Áö¹æ ¾Æ¹Ìµå ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 4¾ï 2,820¸¸ ´Þ·¯·Î ÃßÁ¤µÇ°í, 2024³âºÎÅÍ 2031³â±îÁö ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR) 4.1%·Î ¼ºÀåÇÒ Àü¸ÁÀ̸ç, 2031³â¿¡´Â 5¾ï 6,810¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
º¸°í ¹üÀ§ |
º¸°í¼ ¼¼ºÎÁ¤º¸ |
±âÁسâ |
2023³â |
2023³â ¹× 2024³â ½ÃÀå ±Ô¸ð |
4¾ï 2,820¸¸ ´Þ·¯ |
½ÇÀû µ¥ÀÌÅÍ |
2019-2023³â |
¿¹Ãø ±â°£ |
2024-2031³â |
¿¹Ãø±â°£ 2023³â ¹× 2024³â-2030³â ¹× 2031³â CAGR : |
4.10% |
2030³â ¹× 2031³â °¡Ä¡ ¿¹Ãø |
5¾ï 6,810¸¸ ´Þ·¯ |
±×¸² 1. Áö¹æ ¾Æ¹Ìµå ½ÃÀåÀÇ Áö¿ªº° Á¡À¯À²(%)(2024³â)

¼¼°èÀÇ Áö¹æ ¾Æ¹Ìµå ½ÃÀåÀº ÇÃ¶ó½ºÆ½, °í¹«, ÆäÀÎÆ® µî ´Ù¾çÇÑ ÃÖÁ¾ ÀÌ¿ë »ê¾÷¿¡¼ÀÇ ¿ëµµ È®´ë·Î ÃÖ±Ù ¸î ³â°£ ÇöÀúÇÑ ¼ºÀåÀ» ÀÌ·ç°í ÀÖ½À´Ï´Ù. Áö¹æ ¾Æ¹Ìµå´Â ÁÖ·Î ÀÌ·¯ÇÑ »ê¾÷¿¡¼ À±È°Á¦, À¯µ¿ ÃËÁøÁ¦, ºí·ç¹Ö ¹æÁöÁ¦·Î »ç¿ëµË´Ï´Ù. Áö¹æ ¾Æ¹Ìµå´Â ¿ì¼öÇÑ ¿ ¾ÈÁ¤¼º, ³»¾àǰ¼º, ³ÐÀº ¾×¼º ¹üÀ§¿Í °°Àº ¿ì¼öÇÑ Æ¯¼ºÀ» °®Ãß°í ÀÖ½À´Ï´Ù. °Ô´Ù°¡, Àç»ý°¡´ÉÇÑ µ¿½Ä¹° À¯·¡ÀÇ Áö¹æ ¾Æ¹Ìµå´Â ¼®À¯ À¯·¡ Á¦Ç°¿¡ ´ëÇÑ ÀÇÁ¸µµ¸¦ ³·Ãߴµ¥ µµ¿òÀÌ µÇ¾î ½ÃÀå ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ¿ø·á °¡°Ý º¯µ¿Àº ¿©ÀüÈ÷ Áß¿äÇÑ °úÁ¦ÀÔ´Ï´Ù. ±×·¯³ª ¹ÙÀÌ¿À ÈÇй°ÁúÀÇ Áö¼Ó°¡´É¼º°ú ÀåÁ¡¿¡ ´ëÇÑ ÀǽÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó Áö¹æ¾Æ¹Ìµå Á¦Á¶¾÷üÀÇ ºñÁî´Ï½º ±âȸ°¡ È®´ëµÇ°í ÀÖ½À´Ï´Ù. Áö¹æ ¾Æ¹Ìµå´Â Á¾Á¾ Áö¹æ»ê ¾Æ¹Ìµå¶ó°í ºÒ¸®¸ç, OH ±â°¡ NH2(¾Æ¹Î) ±â·Î ġȯµÈ À¯±â Áö¹æ»êÀÇ À¯µµÃ¼ÀÔ´Ï´Ù. Á¦Ç° À¯Çü¿¡ µû¶ó Áö¹æ ¾Æ¹Ìµå´Â ¿¤Ä«¹Ìµå, ¿Ã·¹ÀÎ ¾Æ¹Ìµå, ½ºÅ׾ƶó¹Ìµå, º£Ç쳪¹Ìµå·Î ±¸º°µË´Ï´Ù. Áö¹æ ¾Æ¹Ìµå¸¦ Æ÷ÇÔÇÑ Á¦Ç°Àº ºñµå, ºÐ¸», ÀϺΠ°æ¿ì¿¡´Â ÆÄ½ºÆ¿ ÇüÅ·ΠÆÇ¸ÅµË´Ï´Ù.
½ÃÀå ¿ªÇÐ :
¼¼°èÀÇ Áö¹æ ¾Æ¹Ìµå ½ÃÀåÀÇ ¼ºÀåÀ» °ßÀÎÇϰí ÀÖ´Â °ÍÀº ÇÃ¶ó½ºÆ½ ¹× °í¹« »ê¾÷ÀÇ ¼ºÀå¿¡ ÀÇÇÑ ¼ö¿ä Áõ°¡, ¹ÙÀÌ¿À ÈÇй°Áú º¸±Þ µîÀÇ ¿äÀÎÀÔ´Ï´Ù. Áö¹æ ¾Æ¹Ìµå´Â ÇÃ¶ó½ºÆ½°ú °í¹«ÀÇ ¹èÇÕ¿¡¼ À±È°Á¦, ÀÌÇüÁ¦, ¾ÈƼ ºí·ÎÅ·Á¦·Î¼ ÁÖ¿ä ¿ëµµ¸¦ ¹ß°ßÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ °í¼º´É Á¦Ç°¿¡ ´ëÇÑ ¿ä±¸°¡ Áõ°¡ÇÔ¿¡ µû¶ó Áö¹æ ¾Æ¹ÌµåÀÇ ¼Òºñ¸¦ µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ÆÊÀ¯, ¾ßÀÚÀ¯, Å丣À¯ µî ¿ø·áÀÇ °¡°Ý º¯µ¿À̳ª ºÒ¾ÈÁ¤ÇÑ °ø±ÞÀÌ Å« °úÁ¦°¡ µÇ°í ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ¼®À¯ÈÇÐ ±â¹Ý Á¦Ç°ÀÇ ¹èÃâ¿¡ ´ëÇÑ ¾ö°ÝÇÑ È¯°æ ±ÔÁ¦´Â ½ÃÀå ¼ºÀåÀ» ¾ïÁ¦Çϰí ÀÖ½À´Ï´Ù. ÇÑÆí, Áö¼Ó°¡´É¼º ¹× ¹ÙÀÌ¿À ÈÇй°Áú¿¡ ´ëÇÑ ¼±È£µµÀÇ º¯È´Â Å« ±âȸ¸¦ °¡Á®¿É´Ï´Ù. ´ë±â¾÷Àº »õ·Î¿î ÀÀ¿ë ºÐ¾ß¿Í ģȯ°æ »ý»ê ±â¼úÀ» °³¹ßÇϱâ À§ÇØ ¿¬±¸°³¹ß¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù.
º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡
- º» º¸°í¼¿¡¼´Â Áö¹æ ¾Æ¹Ìµå ½ÃÀåÀ» »ó¼¼ÇÏ°Ô ºÐ¼®ÇÏ¿© 2023³âÀ» ±âÁسâÀ¸·Î ÇÑ ¿¹Ãø±â°£(2024-2031³â) ½ÃÀå ±Ô¸ð ¹× º¹ÇÕ¿¬°£ ¼ºÀå·ü(CAGR%)À» Á¦°øÇÕ´Ï´Ù.
- ¶ÇÇÑ ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀûÀÎ ¼öÀÍ ¼ºÀå ±âȸ¸¦ ¹àÈ÷°í, ÀÌ ½ÃÀå¿¡ ´ëÇÑ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾ÈÀÇ Çà·Ä¿¡ ´ëÇØ ¼³¸íÇÕ´Ï´Ù.
- ¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÌ Ã¤¿ëÇÏ´Â °æÀï Àü·« µî¿¡ °üÇÑ Áß¿äÇÑ ÀλçÀÌÆ®µµ Á¦°øÇÕ´Ï´Ù.
- ±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, À繫 ½ÇÀû, Àü·« µîÀÇ ¸Å°³º¯¼ö¿¡ µû¶ó Áö¹æ ¾Æ¹Ìµå ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À» ÇÁ·ÎÆÄÀϸµÇÕ´Ï´Ù.
- ÀÌ º¸°í¼ÀÇ ÀλçÀÌÆ®¸¦ ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯Çü ¾÷±×·¹À̵å, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü¼ú¿¡ ´ëÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.
- Áö¹æ ¾Æ¹Ìµå ½ÃÀå º¸°í¼´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô Âü°¡ÀÚ, À繫 ºÐ¼®°¡ µîÀÌ ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ °ü°èÀÚ¸¦ Áö¿øÇÕ´Ï´Ù.
¸ñÂ÷
Á¦1Àå Á¶»çÀÇ ¸ñÀû ¹× ÀüÁ¦Á¶°Ç
Á¦2Àå ½ÃÀå Àü¸Á
- º¸°í¼ ¼³¸í
- ÁÖ¿ä ¿ä¾à
- Coherent Opportunity Map(COM)
Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦ ¹× µ¿Ç⠺м®
- ½ÃÀå ¿ªÇÐ
- ÆÛ½º³ÎÄÉ¾î ¾÷°è·ÎºÎÅÍ ¼ö¿ä Áõ°¡
- ´ëüǰÀÇ À̿밡´É¼º
- Æ´»õ ¾ç½Ä¿¡ ´ëÇÑ Áö¹æ»ê ¾Æ¹ÌµåÀÇ Çõ½Å
- ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
- ±ÔÁ¦ ½Ã³ª¸®¿À
- ÃÖ±Ù µ¿Çâ
- Á¦Ç° Ãâ½Ã ¹× ½ÂÀÎ
- PEST ºÐ¼®
- Porter's Five Forces ºÐ¼®
- ÇÕº´, Àμö ¹× Çù¾÷
Á¦4Àå Áö¹æ ¾Æ¹Ìµå ½ÃÀå-Äڷγª ¹ÙÀÌ·¯½º(COVID-19) ÆÒµ¥¹ÍÀÇ ¿µÇâ
- ½ÅÇü Äڷγª ¹ÙÀÌ·¯½º °¨¿°Áõ(COVID-19)ÀÇ ¿ªÇÐ
- °ø±ÞÃø ¹× ¼ö¿äÃø ºÐ¼®
- °æÁ¦Àû ¿µÇâ
Á¦5Àå Áö¹æ ¾Æ¹Ìµå ½ÃÀå : Á¦Ç° À¯Çüº°(2019-2031³â)
- ¿¤Ä«¹Ìµå
- ½ºÅ׾ƶó¹Ìµå
- º£Ç쳪¹Ìµå
- ¿Ã·¹¾Æ¹Ìµå
Á¦6Àå Áö¹æ ¾Æ¹Ìµå ½ÃÀå : Çüź°(2019-2031³â)
- ÆÄ¿ì´õ ¹× ºñÁî
- ¸¶ÀÌÅ©·Î ºñµå
- Æ®·ÎÀÌ
Á¦7Àå Áö¹æ ¾Æ¹Ìµå ½ÃÀå : Áö¿ªº°(2019-2031³â)
- ½ÃÀå Á¡À¯À² ºÐ¼® : Áö¿ªº°(2024³â ¹× 2031³â)(%)
- Àü³â´ëºñ ¼ºÀå ºÐ¼® : Áö¿ªº°(2020-2031³â)
- °¢±¹ÀÇ µ¿Çâ
- ºÏ¹Ì
- ¹Ì±¹
- ij³ª´Ù
- À¯·´
- µ¶ÀÏ
- ¿µ±¹
- ½ºÆäÀÎ
- ÇÁ¶û½º
- ÀÌÅ»¸®¾Æ
- ·¯½Ã¾Æ
- ±âŸ À¯·´
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- Áß±¹
- Àεµ
- ÀϺ»
- È£ÁÖ
- Çѱ¹
- ASEAN
- ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
- ¶óƾ¾Æ¸Þ¸®Ä«
- ºê¶óÁú
- ¾Æ¸£ÇîÆ¼³ª
- ¸ß½ÃÄÚ
- ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
- GCC ±¹°¡
- À̽º¶ó¿¤
- ±âŸ Áßµ¿
- ³²¾ÆÇÁ¸®Ä«
- Áß¾Ó ¾ÆÇÁ¸®Ä«
- ºÏ¾ÆÇÁ¸®Ä«
Á¦8Àå °æÀï ±¸µµ
- ±â¾÷ ÇÁ·ÎÆÄÀÏ
- Lonza
- Novartis International AG
- BASF AG
- SEQENS
- Carbogen Amcis AG
- Eli Lilly and Company
- Teva Pharmaceutical Industries Ltd
- Bristol-Myers Squibb
- Pfizer Inc.
- Roche Diagnostics
- Boehringer Ingelheim
- Merck &Co
- Bayer AG
- Ajinomoto Bio-Pharma Services
- Cambrex Corporation
- Minakem
- Sanofi Aventis
Á¦9Àå ¼½¼Ç
- Âü°í ¹®Çå
- Á¶»ç ¹æ¹ý
- ÃâÆÇ»ç¿¡ ´ëÇØ
AJY
¿µ¹® ¸ñÂ÷
The fatty amides Market size is valued at US$ 428.2 Mn in 2024 and is expected to reach US$ 568.1 Mn by 2031, growing at a compound annual growth rate (CAGR) of 4.1% from 2024 to 2031.
Report Coverage |
Report Details |
Base Year: |
2023 |
Market Size in 2023/2024: |
US$ 428.2 Mn |
Historical Data for: |
2019 to 2023 |
Forecast Period: |
2024 - 2031 |
Forecast Period 2023/2024 to 2030/2031 CAGR: |
4.10% |
2030/2031 Value Projection: |
US$ 568.1 Mn |
Figure 1. Fatty Amides Market Share (%), by Region, 2024

The global fatty amides market has been witnessing significant growth in recent years driven by growing applications in various end-use industries such as plastics, rubber, coatings, and others. Fatty amides are mainly used as lubricants, flow promoters, and anti-blooming agents in these industries. They offer excellent properties such as outstanding thermal stability, chemical resistance, and wide liquid range. Additionally, fatty amides derived from renewable plant and animal sources help reduce dependency on petroleum-based products, thereby boosting the market growth. However, fluctuations in raw material prices remain a key challenge. But growing awareness about sustainability and benefits of bio-based chemicals is expanding opportunities for fatty amides manufacturers. Fatty amides, often termed fatty acid amides, are derivatives of organic fatty acids where an OH group is replaced by an NH2 (amine) group. Depending on the type of product, fatty amides are differentiated as erucamides, oleamides, stearamides, and behenamides. Products containing fatty amides are available in beads, powders, and sometimes also the pastilles form.
Market Dynamics:
The growth of the global fatty amides market is driven by factors such as increasing the demand from the thriving plastics and rubber industries and widespread adoption of bio-based chemicals. Fatty amides find major applications as lubricants, release agents, and anti-blocking agents in plastics and rubber formulations. Additionally, the growing need for high-performance products is propelling the consumption of fatty amides. However, fluctuations in prices and unreliable supply of raw materials such as palm oil, coconut oil, and tall oil pose a major challenge. Furthermore, strict environmental regulations regarding emissions from petrochemical-based products restrain the market growth. Meanwhile, shifting preference toward sustainability and bio-based chemicals presents significant opportunities. Leading players are investing in R&D to develop novel application areas and green production technologies.
Key Features of the Study:
- This report provides an in-depth analysis of the fatty amides market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2024-2031), considering 2023 as the base year
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the fatty amides market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Haihang Industries Co. Ltd., Croda International Plc., PMC Biogenix Inc., Fine Organic Industries Pvt. Ltd., Nippon Fine Chemicals Co., Ltd., Kao Corporation, Italmatch Chemicals S.p.A., Sichuan Tianyu Oleochemical Co., Ltd., and Nippon Kasei Chemical Co., Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The fatty amides market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Detailed Segmentation:
- Fatty Amides Market, By Product Type
- Erucamides
- Oleamides
- Stearamides
- Behenamides
- Fatty Amides Market, By Form
- Powder, Beads
- Micro-beads
- Pastilles
- Fatty Amides Market, By Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
- Top Companies in the Fatty Amides Market:
- Haihang Industries Co. Ltd.
- Croda International Plc.
- PMC Biogenix Inc.
- Fine Organic Industries Pvt. Ltd.
- Nippon Fine Chemicals Co., Ltd.
- Kao Corporation
- Italmatch Chemicals S.p.A.
- Sichuan Tianyu Oleochemical Co., Ltd.
- Nippon Kasei Chemical Co., Ltd
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Fatty Amides Market, By Product Type
- Fatty Amides Market, By Form
- Fatty Amides Market, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Increasing demand from the personal care industry
- Availability of substitutes
- Innovation of fatty amides for niche Forms
- Key Highlights
- Regulatory Scenario
- Recent Trends
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Mergers, Acquisitions, and Collaborations
4. Fatty Amides Market- Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
5. Fatty Amides Market, By Product Type, 2019-2031, (US$ Mn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Erucamide
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
- Stearamide
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
- Behenamide
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
- Oleamide
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
6. Fatty Amides Market, By Form , 2019-2031, (US$ Mn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Powder, Beads
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
- Micro-beads
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
- Pastilles
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
7. Fatty Amides Market , By Region, 2019-2031, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020 - 2031
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
- GCC Countries
- Israel
- Rest of Middle East
- South Africa
- Central Africa
- North Africa
8. Competitive Landscape
- Company Profile
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Novartis International AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Teva Pharmaceutical Industries Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Ajinomoto Bio-Pharma Services
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
9. Section
- References
- Research Methodology
- About us
°ü·ÃÀÚ·á